Actively Recruiting
A Clinical Study of SPH7854 Granules in Healthy Subjects.
Led by Shanghai Pharmaceuticals Holding Co., Ltd · Updated on 2026-05-05
111
Participants Needed
1
Research Sites
135 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the safety of SPH7854 in healthy subjects.
CONDITIONS
Official Title
A Clinical Study of SPH7854 Granules in Healthy Subjects.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Volunteer to participate in clinical research and sign informed consent
- Healthy volunteers
- Normal or clinically insignificant examination results before receiving the investigational drug
- No fertility plan or sperm/egg donation plan and willing to use effective contraception from consent to after last dosing
You will not qualify if you...
- Female subjects who are breastfeeding or have a positive pregnancy test
- Subjects with chronic, unstable, or recurrent diseases or surgery history judged ineligible by the investigator
- Subjects with allergic diseases or history of severe allergies
- Subjects who took prohibited drugs or foods before the first dose
- Subjects with infection evidence deemed ineligible by the investigator
- Other conditions meeting protocol exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
West China Second University Hospital, Sichuan University
Chengdu, China
Actively Recruiting
Research Team
Q
Qin Yu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here